Dr. Moriën
Sources: the KBO register on 19-11-2026; the National Bank, 2025 annual accounts filed on 29-06-2026; the Belgian Official Gazette, latest deed of 06-07-2022.
Grounds
the facts the verdict rests on, each with its source- In 2025, Dr. Moriën closed with a net profit of €58,096.Annual accounts 2025 page 2
- Equity stands at €1.4m, or 96.3% of the balance sheet total of €1.5m. That is more than 95% of the 21,349 companies in the human health sector (NACE 86).Annual accounts 2025 page 2
- Dr. Moriën paid out €900 in dividends, 2% of the profit of 2025.Annual accounts 2025 page 2
- The last five annual accounts came in on time. The 2025 accounts were filed 32 days before the end of the term.National Bank, filing of 29-06-2026 page 4
Representation
The sole director, , represents Dr. Moriën alone.
Articles of association, Belgian Official Gazette of 06-07-2022, deed 22344241
Ownership
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Financial situation
Annual accounts 2021 to 2025, as filed with the National Bank
Gross margin and net resultin €m
Equity and debtsin €m
Cashin €m
| Financial year | 2021 | 2022 | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|---|---|
| Results | ||||||
| Gross margin | €217,106 | €194,078 | €244,969 | €251,159 | €101,969 | |
| Operating result | €150,117 | €121,870 | €169,523 | €176,717 | €64,242 | |
| Net result | €102,863 | €82,859 | €114,016 | €124,163 | €58,096 | |
| Balance sheet at the closing date | ||||||
| Equity | €1.0m | €1.1m | €1.2m | €1.4m | €1.4m | |
| Debts | €304,032 | €316,302 | €305,680 | €322,193 | €54,577 | |
| Debts due after more than one year | €228,026 | €260,188 | €252,896 | €246,162 | - | |
| Debts due within one year | €67,908 | €46,144 | €37,166 | €57,383 | €52,777 | |
| Cash | €257,246 | €294,955 | €43,288 | €61,154 | €74,405 | |
| Balance sheet total | €1.3m | €1.4m | €1.5m | €1.7m | €1.5m | |
| Operations | ||||||
| Employees in full-time equivalents | 1.0 | 1.0 | 1.0 | 1.0 | 0.4 | |
| Ratios | ||||||
| Solvency | 77.5% | 78.1% | 80.2% | 80.9% | 96.3% | |
| Liquidity | 17.82 | 28.79 | 39.46 | 28.63 | 27.44 | |
Source: Annual accounts 2025, micro format, filed on 29-06-2026 (2026-00214968); Annual accounts 2024, micro format, filed on 16-07-2025 (2025-00277356); Annual accounts 2021 to 2023, filed from 12-07-2022 to 27-06-2024 (2022-20173916, 2023-00159678, 2024-00181679).
The operating result of 2025 is 64% lower than in 2024.
Debts fell by €267,615 in 2025.
The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.
Dr. Moriën states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €251,159 to €101,969.
Board, signature and ownership
Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts
Who represents the company
The sole director, , represents Dr. Moriën alone.
Articles of association, Belgian Official Gazette of 06-07-2022, deed 22344241
Board
one director in officeOwnership and group
Shareholders
Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.
Board changes
resigns as manager. reappointed as director. General meeting of 28-04-2022.
Gazette, deed 22344241Capital increase of €225,000 to €243,600. The capital rose from €18,600 to €243,600. reappointed as manager. General meeting of 24-12-2013.
Gazette, deed 14056135Events and comparison
The latest events, newest first
Annual accounts 2025 filed, 32 days before the deadline.
NBB filingAnnual accounts 2024 filed, 15 days before the deadline.
NBB filingRegistered in the Peppol Directory. Reachable for e-invoices through 0208:0859630826.
Annual accounts 2023 filed, 34 days before the deadline.
NBB filingAnnual accounts 2022 filed, 34 days before the deadline.
NBB filingAnnual accounts 2021 filed, 19 days before the deadline.
NBB filingresigns as manager. reappointed as director. General meeting of 28-04-2022.
Gazette, deed 22344241Equity above €1m. After 15 profitable years in a row, equity reaches €1.0m.
FinancialAnnual accounts 2020 filed, 33 days before the deadline.
NBB filingAnnual accounts 2019 filed, 11 days before the deadline.
NBB filingLiquidity more than quadruples. The current ratio rises from 3.30 to 14.16. Short-term debt falls from €298,522 to €76,857.
FinancialAnnual accounts 2018 filed, 12 days before the deadline.
NBB filingCapital decrease of €225,000 to €18,600. The capital fell from €243,600 to €18,600. General meeting of 06-11-2018.
Gazette, deed 18174383Annual accounts 2017 filed, 35 days before the deadline.
NBB filingComparable companies, two years later
In July 2024, 17,047 companies had the same profile as Dr. Moriën has now: micro, 20 years or older, solvency 30% or more and a profit under 5% of the balance sheet. Two years later 94.3% were still trading, 5.2% had stopped another way and 0.5% had gone bankrupt.
In 2025, Dr. Moriën had a lower net result than 51% of the 21,334 companies in the human health sector (NACE 86).
Other findings
Peppol
Reachable for e-invoices since 23-02-2025, under 0208:0859630826.
Sanctions lists
Staff
1 employee on 31-12-2024, 0.8 full-time equivalents on average over the year.
Sources and method
Where each fact in this report comes from
| Source | What | Date | Reference |
|---|---|---|---|
| KBO register | Registration, legal situation, activity, establishment units | 19-11-2026 | KBO 0859.630.826 |
| National Bank of Belgium | Annual accounts 2025, micro format | 29-06-2026 | 2026-00214968 |
| National Bank of Belgium | Annual accounts 2024, micro format | 16-07-2025 | 2025-00277356 |
| National Bank of Belgium | Annual accounts 2021 to 2023 | 12-07-2022 to 27-06-2024 | 2022-20173916, 2023-00159678, 2024-00181679 |
| Belgian Official Gazette | Articles of association with the signing rule | 06-07-2022 | deed 22344241 |
| Belgian Official Gazette | Board | 05-03-2014 | deed 14056135 |
| Peppol Directory | Registration for e-invoices | 23-02-2025 | 0208:0859630826 |
| Sanctions lists EU, UN, US (OFAC) and UK | Comparison of the name | 16-11-2026 | no match |
| Checked | Checked score, bankruptcy probability, credit, comparable companies | 18-11-2026 | bankruptcy model of 2 October 2026 |
Method
Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.
Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.
Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.
Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.
Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.
The scores and ratios are Checked's own calculations, not a credit decision.